Comera Life Sciences Holdings, Inc. (CMRA)

0.0268 +0.0056 (+26.60%) 收市：11:08AM EDT

Comera Life Sciences Holdings, Inc.

12 Gill Street
Suite 4650
Woburn, MA 01801
United States
617 871 2101
https://comeralifesciences.com

版塊: Healthcare
行業: Biotechnology
全職員工: 12

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Michael G. Campbell CPA	CEO, CFO & Principal Accounting Officer	269.11k	無	1969
Dr. David Soane Ph.D.	Co-Founder & Member of Scientific Advisory Board	無	無	無
Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph.	Chief Business Officer	無	無	1962

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

公司管治

截至 無 止，Comera Life Sciences Holdings, Inc. 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。